Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex
Subacute sclerosing panencephalitis (SSPE) is a late-onset and fatal viral disease caused by persistent infection of the central nervous system by measles virus (MeV). We present the case of a 10-year-old child from South Asia affected by SSPE, stabilized with a combination of intrathecal interferon...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2022.2148563 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850155755237277696 |
|---|---|
| author | Renan Le Cras Roseline Mazet Fanny Dubois-Teklali Cécile Sabourdy Sébastien Chanoine Audrey Lehmann Agathe Morin Julien Leenhardt Marjorie Durand Marie-Dominique Desruet Pierrick Bedouch |
| author_facet | Renan Le Cras Roseline Mazet Fanny Dubois-Teklali Cécile Sabourdy Sébastien Chanoine Audrey Lehmann Agathe Morin Julien Leenhardt Marjorie Durand Marie-Dominique Desruet Pierrick Bedouch |
| author_sort | Renan Le Cras |
| collection | DOAJ |
| description | Subacute sclerosing panencephalitis (SSPE) is a late-onset and fatal viral disease caused by persistent infection of the central nervous system by measles virus (MeV). We present the case of a 10-year-old child from South Asia affected by SSPE, stabilized with a combination of intrathecal interferon-α2b (INF-α2b) injections and oral inosiplex and how we continued the treatment when inosiplex was commercially stopped worldwide. |
| format | Article |
| id | doaj-art-187b3989c0384bb4b321e957f8224289 |
| institution | OA Journals |
| issn | 2222-1751 |
| language | English |
| publishDate | 2023-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Emerging Microbes and Infections |
| spelling | doaj-art-187b3989c0384bb4b321e957f82242892025-08-20T02:24:47ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512023-12-0112110.1080/22221751.2022.2148563Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplexRenan Le Cras0Roseline Mazet1Fanny Dubois-Teklali2Cécile Sabourdy3Sébastien Chanoine4Audrey Lehmann5Agathe Morin6Julien Leenhardt7Marjorie Durand8Marie-Dominique Desruet9Pierrick Bedouch10Pharmacy Department, Grenoble University Hospital, Grenoble, FrancePharmacy Department, Grenoble University Hospital, Grenoble, FrancePediatric Neurology Unit, Grenoble University Hospital, Grenoble, FranceNeurology Unit, Grenoble University Hospital, Grenoble, FrancePharmacy Department, Grenoble University Hospital, Grenoble, FrancePharmacy Department, Grenoble University Hospital, Grenoble, FrancePharmacy Department, Grenoble University Hospital, Grenoble, FrancePharmacy Department, Grenoble University Hospital, Grenoble, FrancePharmacy Department, Grenoble University Hospital, Grenoble, FrancePharmacy Department, Grenoble University Hospital, Grenoble, FrancePharmacy Department, Grenoble University Hospital, Grenoble, FranceSubacute sclerosing panencephalitis (SSPE) is a late-onset and fatal viral disease caused by persistent infection of the central nervous system by measles virus (MeV). We present the case of a 10-year-old child from South Asia affected by SSPE, stabilized with a combination of intrathecal interferon-α2b (INF-α2b) injections and oral inosiplex and how we continued the treatment when inosiplex was commercially stopped worldwide.https://www.tandfonline.com/doi/10.1080/22221751.2022.2148563Inosiplexinosine pranobexspeciality commercially stoppedmagistral preparationsubacute sclerosing panencephalitis (SSPE) |
| spellingShingle | Renan Le Cras Roseline Mazet Fanny Dubois-Teklali Cécile Sabourdy Sébastien Chanoine Audrey Lehmann Agathe Morin Julien Leenhardt Marjorie Durand Marie-Dominique Desruet Pierrick Bedouch Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex Emerging Microbes and Infections Inosiplex inosine pranobex speciality commercially stopped magistral preparation subacute sclerosing panencephalitis (SSPE) |
| title | Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex |
| title_full | Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex |
| title_fullStr | Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex |
| title_full_unstemmed | Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex |
| title_short | Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex |
| title_sort | place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide a case report of a 10 year old child with subacute sclerosing panencephalitis sspe requiring inosiplex |
| topic | Inosiplex inosine pranobex speciality commercially stopped magistral preparation subacute sclerosing panencephalitis (SSPE) |
| url | https://www.tandfonline.com/doi/10.1080/22221751.2022.2148563 |
| work_keys_str_mv | AT renanlecras placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex AT roselinemazet placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex AT fannyduboisteklali placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex AT cecilesabourdy placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex AT sebastienchanoine placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex AT audreylehmann placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex AT agathemorin placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex AT julienleenhardt placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex AT marjoriedurand placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex AT mariedominiquedesruet placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex AT pierrickbedouch placeofmagistralpreparationstocontinuethetreatmentifthedrugiscommerciallystoppedworldwideacasereportofa10yearoldchildwithsubacutesclerosingpanencephalitisssperequiringinosiplex |